November 8, 2018
Illumina, the dominant maker of DNA sequencing machines, will buy rival Pacific Biosciences for $1.2B in order to cement its ownership of cutting-edge genetic research. The […]
November 8, 2018
Researchers at MIT have developed a new way for drug sponsors and researchers to share information without compromising patient privacy or intellectual property. There have been […]
February 7, 2019
The industry’s year ahead will be shaped by trends impacting biopharma’s perception, investment and future growth. Criticism and scrutiny from lawmakers will likely remain, scientific advances […]
February 7, 2019
Sandoz has launched its epinephrine injection Symjepi. A twinpack will have a wholesale acquisition cost of $250, around 16.5% less than Mylan and Teva’s generic EpiPens. […]
February 7, 2019
DNA testing company 23andMe has gotten approval from the FDA for a consumer test detecting hereditary colorectal cancer syndrome by determining whether customers have two genetic […]
February 7, 2019
Former Fierce 15 winner Proteus Digital Health has launched an oral chemotherapy equipped with an ingestible sensor, helping oncologists track treatment effectiveness and patient adherence. […]
February 7, 2019
Recently, pharma companies have been consolidating their businesses around core therapeutic areas to improve productivity and focus R&D investment. With these consolidations occurring, BioPharma Dive decided […]
March 8, 2019
Pharma companies do their best to fight patent expirations and generic competition to protect their top-selling drugs, but 2019 looks like the end of the line […]
March 15, 2019
NCI Director Ned Sharpless will become the interim leader of the FDA in early April once Scott Gottlieb’s resignation becomes effective, says HHS Secretary Alex Azar. […]